How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Nulojix cost savings if eligible
With our assistance, you could access the Nulojix patient assistance program and obtain your medication for free. We only charge a flat monthly fee of $49 per medication for our services.
Am I eligible for Nulojix patient assistance?
We review each Nulojix enrollment application individually to determine if you are eligible. Each assistance program has its own eligibility criteria and the factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Nulojix patient assistance program?
Our process makes it as easy as possible to apply for the Nulojix patient assistance program. Begin by completing the enrollment application form on our website. Tell us about any medications that you are taking, including Nulojix, your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers who will supply the medication, so it is important to make sure this information is accurate and up to date.
We will review the information that you have provided to determine whether you are eligible for patient assistance. If we can pre-qualify you for assistance, NiceRx will handle the full enrollment process on your behalf. If you are approved by the pharmaceutical company, you will typically start receiving your medication in 6 – 8 weeks.
Is NiceRx a Nulojix coupons provider?
NiceRx is not a Nulojix coupon, Nulojix discount card, or Nulojix copay card provider. We do not offer Nulojix manufacturer coupons, Nulojix discounts, rebates, Nulojix savings cards, trial offers, or free Nulojix samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Can NiceRx help me if I have insurance?
NiceRx may be able to help you if:
- You have a high copay or coinsurance responsibility for Nulojix
- Your insurance company will not pay for your Nulojix prescription
- Your healthcare plan does not cover your medication
- You do not have insurance
Please apply online to find out if we can help you.
How much does Nulojix cost without insurance?
Without insurance, Nulojix costs will vary depending on where you buy the medication as prices will vary by retailer. As a guide, Nulojix intravenous powder for injection 250 mg will cost around $1000 for 1 powder for injection.
How much does Nulojix cost with insurance?
The copay for Nulojix will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Nulojix?
Nulojix is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Bristol-Myers Squibb Company.
Nulojix is a selective T-cell costimulation blocker indicated for prophylaxis of organ rejection in adult kidney transplant recipients. It is used in combination with basiliximab induction, mycophenolate mofetil, and corticosteroids. Only use in patients who are EBV seropositive. Use has not been established for the prophylaxis of organ rejection in transplanted organs other than the kidney.
Increased risk for developing post-transplant lymphoproliferative disorder (PTLD), mainly involving the central nervous system (CNS). Patients without immunity to Epstein-Barr virus (EBV) are at increased risk therefore, use in EBV seropositive patients only. Do not use in transplant recipients who are EBV seronegative or with unknown serostatus. Only physicians experienced in immunosuppressive therapy and management of kidney transplant patients should prescribe Nulojix. Increased susceptibility to infection and the possible development of malignancies may result from immunosuppression. Use in liver transplant patients is not recommended due to an increased risk of graft loss and death.
What doses of Nulojix are available?
Nulojix is available in lyophilized powder for injection form, in the following doses: 250 mg per vial.
Dosing for Initial Phase:
- Day 1 (day of transplantation, prior to implantation) and Day 5 (approximately 96 hours after Day 1 dose) 10 mg per kg
- End of Week 2 and Week 4 after transplantation – 10 mg per kg
- End of Week 8 and Week 12 after transplantation – 10 mg per kg
Dosing for Maintenance Phase:
- End of Week 16 after transplantation and every 4 weeks (plus or minus 3 days) thereafter – 5 mg per kg.
For intravenous infusion only, administer over 30 minutes. Only use the enclosed silicone-free disposable syringe to prepare for administration.
Please see the full prescribing information, including “What is the most important information I should know about Nulojix?” in the Medication Guide. Always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Nulojix active ingredients
The active ingredient of Nulojix is belatacept, which weakens your body’s immune system, to stop it from “rejecting” a transplanted organ such as a kidney.
Nulojix side effects
The most common side effects of Nulojix in clinical trials include:
- Anemia, hypokalemia, hyperkalemia, and leukopenia (low white blood cells)
- Diarrhea, constipation
- Nausea, vomiting, headache, cough
- Urinary tract infection
- Peripheral edema
- Hypertension (high blood pressure)
- Graft dysfunction
In rare instances, Nulojix can cause more serious adverse reactions. These can include:
- Post-Transplant Lymphoproliferative Disorder (PTLD)- see Boxed Warning
- Other malignancies
- Progressive Multifocal Leukoencephalopathy (PML)
- Other serious infections – increased risk of bacterial, viral, fungal, and protozoal infections, including opportunistic infections and tuberculosis. Polyoma virus-associated nephropathy can lead to kidney graft loss
- Acute rejection and graft loss with corticosteroid minimization
- Coadministration with anti-thymocyte globulin in de novo kidney transplant recipients, especially those with other risk factors for venous thrombosis of the renal allograft, coadministration with anti-thymocyte globulin may pose a risk for venous thrombosis of the renal allograft
- Risk of rejection with the conversion from a CNI based maintenance regimen – conversion of maintenance kidney transplant recipients from a CNI based to Nulojix based maintenance regimen increases the risk of acute rejection. Conversion of stable kidney transplant recipients from a CNI based maintenance therapy to belatacept-based maintenance therapy is not recommended unless the patient is CNI intolerant
Your doctor will assess the benefits of using Nulojix against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Nulojix to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Nulojix drug interactions
Nulojix can interact with other medications. These include:
- Mycophenolate mofetil (MMF) – when patients are switched between cyclosporine and Nulojix therapy
- Immunizations – avoid the use of live vaccines during treatment
This list is not exhaustive and other prescription drugs may interact with Nulojix.
You should not use Nulojix if you:
- Are allergic to the active ingredient belatacept
- Are allergic to any of the other ingredients in Nulojix
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed
Talk to your doctor before using Nulojix if you:
- Are taking any of the medications that could interact with Nulojix
- Have other known risk factors for PTLD include cytomegalovirus (CMV) infection and T cell-depleting therapy
Nulojix is the trademark brand name for belatacept manufactured by Bristol-Myers Squibb Company. A generic version of belatacept is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Nulojix savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.